A detailed history of Kestra Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kestra Investment Management, LLC holds 7,357 shares of ABBV stock, worth $1.35 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
7,357
Previous 7,108 3.5%
Holding current value
$1.35 Million
Previous $1.26 Billion 22.03%
% of portfolio
0.06%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 16, 2025

BUY
$169.2 - $216.66 $340,430 - $435,919
2,012 Added 27.35%
9,369 $1.96 Billion
Q1 2025

May 15, 2025

BUY
$169.2 - $216.66 $42,130 - $53,948
249 Added 3.5%
7,357 $1.54 Billion
Q4 2024

Jan 31, 2025

BUY
$164.99 - $203.87 $260,519 - $321,910
1,579 Added 28.56%
7,108 $1.26 Billion
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $905,871 - $1.1 Million
5,529 New
5,529 $1.09 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $325B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Kestra Investment Management, LLC Portfolio

Follow Kestra Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Investment Management, LLC with notifications on news.